New Prez, New Studies: New Era for Stem Cells?

As the dust settles from the U.S. Food and Drug Administration's approval of the first-ever study of a treatment based on human embryonic stem cells, researchers are now assessing what this trial may mean for the years to come in stem cell research -- and how the politics of the past decade may have damaged their progress. The study, for which California based Geron Corp. won FDA approval on Friday, will examine the potential of an embryonic stem cell treatment in fixing severe spinal cord...Full Story
Commenting on this article is closed.